Data Foundry

Medical device recalls 2022

Randox Cholesterol- For the quantitative in vitro determination of… — Class II medical device recall Z-1424-2022

Terminated recall by Randox Laboratories Ltd., reported 2022-07-27, distributed nationwide. Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using

Recall numberZ-1424-2022
Product typeMedical device
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmRandox Laboratories Ltd., Crumlin (North), N/A, Ireland
Recall initiated2022-06-22
Classified2022-07-20
Reported by FDA2022-07-27
Terminated2024-05-10
DistributedNationwide (US)
Quantity15 kits
UPC / GTIN / UDI-DI05055273201130
Lot numbers28TH, 586177
Model numbersCH2O0

Product

Randox Cholesterol- For the quantitative in vitro determination of Cholesterol in serum and plasma. Catalog Number: CH2O0

Reason for recall

Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the recommended calibration material CAL2351, the product fails to meet its linearity performance claim quoted on the kit inserts. The linearity is reduced by up to -35% however Quality Control results will still fall within assigned ranges. This may lead to delayed results.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-1424-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.